Evidence map›Paper›PMID 35889766›Full record

ArticleNutrients2022

Thymol Alleviates LPS-Induced Liver Inflammation and Apoptosis by Inhibiting NLRP3 Inflammasome Activation and the AMPK-mTOR-Autophagy Pathway.

Xiujing Dou, Di Yan, Siqi Liu, Lujia Gao, Anshan Shan

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Inflammasomes and autophagy in cancer: unlocking targeted therapies.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Therapeutic effects ofFrontiers in pharmacology · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xiujing DouInstitute of Animal Nutrition, Northeast Agricultural University, Harbin 150030, China.
Di YanInstitute of Animal Nutrition, Northeast Agricultural University, Harbin 150030, China.
Siqi LiuInstitute of Animal Nutrition, Northeast Agricultural University, Harbin 150030, China.
Lujia GaoInstitute of Animal Nutrition, Northeast Agricultural University, Harbin 150030, China.
Anshan ShanInstitute of Animal Nutrition, Northeast Agricultural University, Harbin 150030, China.
Northeast Agricultural University · CN

Funding

China Postdoctoral Science Foundation 2021T140103Department of Education, Heilongjiang Province UNPYSCT-2020094Heilongjiang Provincial Postdoctoral Science Foundation LBH-TZ2005National Natural Science Foundation of China 32172751
6 · The paper itself

Abstract

Thymol is a natural antibacterial agent found in the essential oil extracted from thyme, which has been proven to be beneficial in food and medicine. Meanwhile, the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome and autophagy have been reported to play key roles in the progression of liver injury. However, the effects of thymol on the NLRP3 inflammasome and autophagy in protecting the liver remain unclear. The present study used a mouse model with liver injury induced by lipopolysaccharides (LPS) to investigate the regulatory mechanisms of thymol. We found that thymol alleviated LPS-induced liver structural damage, as judged by reduced inflammatory cell infiltration and improved structure. In addition, elevated levels of the liver damage indicators (alanine transaminase (ALT), aspartate transaminase (AST), and total bilirubin (TBIL)) dropped after thymol administration. The mRNA and protein expression of inflammatory cytokines (tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-22), apoptosis-related genes (caspase3 and caspase9), and the activity of apoptosis-related genes (caspase3 and caspase9) were increased in LPS-treated livers, whereas the changes were alleviated after thymol administration. Thymol inhibited LPS-induced increment in lactate dehydrogenase (LDH) activity in primary hepatocytes of the mouse. In addition, thymol protected mice from liver injury by inhibiting NLRP3 inflammasome activation induced by LPS. Mechanistically, the present study indicates that thymol has liver protective activity resulting from the modulation of the AMP-activated protein kinase-mammalian target of rapamycin (AMPK-mTOR) to regulate the autophagy pathway, hence curbing inflammation.

Indexed as

HepatitisThymolAMP-Activated Protein KinasesAnimalsApoptosisAutophagyInflammasomesInflammationLipopolysaccharidesMiceNLR Family, Pyrin Domain-Containing 3 ProteinTOR Serine-Threonine KinasesTumor Necrosis Factor-alphaAMP-Activated Protein KinasesInflammasomesLipopolysaccharidesNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseThymolTOR Serine-Threonine KinasesTumor Necrosis Factor-alphaautophagyinflammationliver injurymTORNLRP3 inflammasomethymol

Identifiers

PMID35889766
PMCPMC9319298
OpenAlexW4285004887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.